BioCryst Pharmaceuticals
BCRX
#4669
Rank
S$2.06 B
Marketcap
$9.89
Share price
-0.40%
Change (1 day)
56.01%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : S$1.29 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are S$1.29 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$1.31 B2.27%
2023-12-31S$1.28 B13.43%
2022-12-31S$1.13 B20.48%
2021-12-31S$0.93 B100.68%
2020-12-31S$0.46 B153.48%
2019-12-31S$0.18 B38.54%
2018-12-31S$0.13 B5.51%
2017-12-31S$0.12 B-1.07%
2016-12-31S$0.12 B21.01%
2015-12-31S$0.10 B30.47%
2014-12-31S$80.91 M27.75%
2013-12-31S$63.33 M-10.53%
2012-12-31S$70.79 M-18.89%
2011-12-31S$87.28 M54.21%
2010-12-31S$56.6 M-27.9%
2009-12-31S$78.51 M43.47%
2008-12-31S$54.72 M-51.13%
2007-12-31S$0.11 B54.28%
2006-12-31S$72.57 M6.82%
2005-12-31S$67.94 M1228.77%
2004-12-31S$5.11 M82.58%
2003-12-31S$2.8 M37.72%
2002-12-31S$2.03 M-51.87%
2001-12-31S$4.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$1.14 B-11.32%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.25 B 152.02%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.58 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.91 B 126.03%๐Ÿ‡บ๐Ÿ‡ธ USA
S$53.11 B 4,013.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$60.57 M-95.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$77.76 B 5,922.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$1.21 B-6.15%๐Ÿ‡บ๐Ÿ‡ธ USA
S$19.22 M-98.51%๐Ÿ‡บ๐Ÿ‡ธ USA